The Mater Private Network has announced €4.5 million investment in its cancer care services in the mid-west region in 2025.
The investment was outlined at an event to celebrate an important treatment milestone of the Halcyon Linac radiotherapy treatment system at Mid-West Radiation Oncology Centre (MWROC) in Limerick, and will bring innovative oncology treatments to patients across Munster.
This investment brings the total investment in the MWROC above €10m over the past five years. The Network’s plans for 2025 build on the pre-existing commitment to operate a Centre of Excellence on the Limerick premises and will see the addition of stereotactic radiation to the centre’s suite of treatment options.
Speaking at the Centre’s milestone presentation, CEO of Mater Private Network, John Hurley said, “This milestone is a testament to Mater Private Network’s unwavering commitment to investing in cutting-edge technology, patient care, and the communities we serve. Over the past 20 years, the Mid-West Radiation Oncology Centre has played a pivotal role in the cancer journeys of thousands of patients, enabling world-class care without the need to travel. As we look to the future, continued investment in these services will ensure patients across the mid-west and beyond have access to the most advanced treatments available.”
Since its establishment in 2005, MWROC has treated over 15,500 patients from across Munster and is the only specialist radiotherapy facility in the region. Offering treatment through Ireland’s first Halcyon Linear Accelerator, over 1,500 patients with a range of cancer types have been treated since it was installed in July 2023, with a 50% reduction in treatment times and enhanced patient comfort.
